nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2020, 10, v.27 1158-1161
恶性肿瘤合并静脉血栓患者临床特点及预后的研究
基金项目(Foundation): 陕西省重点研发计划项目(2021SF-058)
邮箱(Email):
DOI: 10.13455/j.cnki.cjcor.2020.10.02
摘要:

目的探讨恶性肿瘤合并静脉血栓栓塞症(VTE)患者的临床特点,并对其预后进行随访研究。方法选取2018年1月至2019年12月间陕西省人民医院收治的120例恶性肿瘤患者,收集患者年龄、性别、恶性肿瘤类型和临床表现等相关资料,总结恶性肿瘤合并VTE临床特点,对其治疗及预后进行随访观察。结果 120例恶性肿瘤患者中,45例发生VTE。单纯恶性肿瘤组与恶性肿瘤合并VTE组患者在年龄、合并疾病、白细胞计数、血红蛋白、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)以及D-二聚体方面比较,差异均有统计学意义(均P <0.05)。多因素Logistic回归分析显示,恶性肿瘤合并VTE与糖尿病、长期卧床、VTE病史、肿瘤压迫和感染等因素有关(均P <0.05)。恶性肿瘤合并VTE肿瘤类型以肺癌为主(31.1%),其次为消化道肿瘤(22.2%);临床症状以呼吸困难为主(84.4%),其次为发热(55.6%)。VTE主要发生在恶性肿瘤确诊后3个月内(53.3%),患者经过低分子肝素治疗,有效28例,无效12例,死亡5例。结论恶性肿瘤合并VTE多发于恶性肿瘤确诊3个月内,症状以呼吸困难和发热为主,与糖尿病、长期卧床和肿瘤压迫等因素有关,预后较差,应给予高度关注。

Abstract:

Objective To observe the clinical characteristics in patients with malignant tumors complicated with venous thromboembolism(VTE),and to follow up the prognosis.Methods From January 2018 to December 2019,120 patients with malignant tumor admitted to Shaanxi Provincial People's Hospital were selected as the research subjects.The occurrence of VTE was observed,and the relevant data such as age,gender,type of malignant tumor and clinical manifestation were collected.The clinical characteristics of malignant tumor combined with VTE were summarized,and the treatment and prognosis were followed-up.Results Among 120 patients with malignant tumor,45(37.5%) had VTE.There were significant differences in age,disease,leukocyte count,hemoglobin,prothrombin time(PT),activated partial thromboplastin time(APTT) and D-dimer between malignant tumor group and VTE group(all P < 0.05).Multivariate logistic regression analysis showed that malignant tumor complicated with VTE was associated with diabetes mellitus,long-term bed rest,history of VTE,tumor compression,infection and hormone therapy(all P < 0.05).Lung cancer(31.1%) was the main type of malignant tumor complicated with VTE followed by digestive tract tumor(22.2%).Dyspnea(84.4%) was the main clinical symptom followed by fever(55.6%).VTE(53.3%) mainly occurred within 3 months after the diagnosis of malignant tumor.After treatment with low molecular weight heparin,efficacy was achieved in 28 patients,inefficacy was observed in 12 patients and 5 patients died.Conclusion VTE complicated with malignant tumors often occures within 3 months after the diagnosis of malignant tumors.The main symptoms include dyspnea and fever,which are related to diabetes mellitus,long-term bed rest and tumor compression.The prognosis is poor,so particular attention should be given to it.

参考文献

[1]钟绿,汤绍辉.低分子量肝素对恶性肿瘤合并静脉血栓栓塞症患者生存影响的Meta分析[J].中国全科医学,2018,21:595-603.

[2]乔力松,许小毛,杨鹤,等.肺癌、消化及泌尿系恶性肿瘤合并静脉血栓栓塞症的临床特点及预后比较[J].中华医学杂志,2018,98:1403-1407.

[3]王媛,李思雨,辜瑜.恶性肿瘤手术患者医患共享决策制定的参与情况及影响因素[J].中国肿瘤临床与康复,2019,26:743-746.

[4]李诚,兰莉,杨超,等. 2015-2017年哈尔滨市恶性肿瘤发病与死亡特征分析[J].实用肿瘤学杂志,2019,33:68-72.

[5]Kim HJ,Seo JW,Roh MS,et al. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen[J]. J Am Acad Dermatol,2018,25:462-468.

[6]孙莹,贾茗博,宋燕珂,等.组织因子在恶性肿瘤合并静脉血栓栓塞中作用的研究进展[J].中国实验诊断学,2020,24:336-339.

[7]赵金璐,李国东,刘明.长链非编码RNA CCAT1与消化系统恶性肿瘤关系的研究进展[J].实用肿瘤学杂志,2019,33:367-370.

[8]Hong-Fang LU,Xiao-Ning LI,Jiang-Long Z,et al. Risk evaluation and risk factors distribution analysis of venous thromboembolism in hospitalized patients of general surgery department[J]. Clin Res Pract,2018,31:264-266.

[9]莫才连,张晖,王士勇,等. 99例晚期恶性肿瘤患者静脉血栓栓塞症的诊治情况分析[J].现代肿瘤医学,2020,28:1186-1189.

[10]Jing Z,Dong-Lai LU,Jun-Ping Z,et al. Analysis of clinical characteristics and prognostic factors of patients with vertebral metastatic carcinoma treated by radiotherapy[J]. J Cervicodynia Lumbodynia,2019,13:127-128.

[11]陈慧敏,赵冬,王明珠.老年恶性肿瘤患者并发弥散性血管内凝血危险因素及对预后的影响[J].中国肿瘤临床与康复,2018,25:1499-1501.

[12]刘胜楠,陆胜莲,顾仲毅,等.妇科恶性肿瘤手术患者静脉血栓栓塞症危险因素分析及风险评估表的应用[J].第二军医大学学报,2017,38:1244-1249.

[13]马超,韩劲松.结直肠手术术后静脉血栓栓塞症发生率的meta分析[J].中国普外基础与临床杂志,2020,27:182-191.

[14]Wang YG,Shi ZY,Fu WG,et al. Curative effect of the rivaroxaban and the low-molecular weight heparin anticoagulation in patients with active malignant tumors combined with venous thromboembolism[J]. Fudan Univ J Med Sci,2018,21:228-230.

基本信息:

DOI:10.13455/j.cnki.cjcor.2020.10.02

中图分类号:R730.6

引用信息:

[1]周伟,段荣军,周佐超.恶性肿瘤合并静脉血栓患者临床特点及预后的研究[J].中国肿瘤临床与康复,2020,27(10):1158-1161.DOI:10.13455/j.cnki.cjcor.2020.10.02.

基金信息:

陕西省重点研发计划项目(2021SF-058)

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文